ENTERA BIO LTD's ticker is ENTX and the CUSIP is M40527109. A total of 12 filers reported holding ENTERA BIO LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,425 | +11.8% | 13,000 | +30.0% | 0.00% | – |
| Q2 2023 | $8,430 | -27.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $11,600 | +58.9% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $7,300 | -27.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | -23.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -55.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,791,363 | $6,825,000 | 4.45% |
| XTX Topco Ltd | 11,559 | $44,000 | 0.02% |
| Renaissance Technologies | 120,407 | $459,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 21,999 | $84,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 38,611 | $147,000 | 0.00% |
| Clearstead Advisors, LLC | 500 | $2,000 | 0.00% |
| Allworth Financial LP | 100 | $0 | 0.00% |
| UBS Group AG | 1,614 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |